glp 1 drugs for binge eating disorder GLP-1 obesity and disorders are not well understood yet : NPR Neurobiological Mechanisms and Therapeutic Potential

Metabolic dysfunction-associated steatotic liver disease (MASLD) MASLD is the most prevalent CLD globally, with a global prevalence of approximately 32% (estimated in 2022) and is strongly associated with obesity, dyslipidemia, and insulin resistance 46,47

It helps move long-chain fatty acids into the mitochondria, where cells make ATP

This effect is believed to be linked to reduced oxidative stress and improved mitochondrial efficiency

composition: Glycolic Acid 2%, Niacinamide 0.5%, Glutathione 0.1%, Kojic Acid 0.25%, Triclosan 0.3%, Vitamin C 0.5%, Aloe Vera 2%, Glycerine 5% & Vitamin E Beads

J Proteom

References [1] Yang B, Liu Y, Li Y, et al